Sevoflurane inhibits the progression of ovarian cancer through down-regulating stanniocalcin 1 (STC1)

BACKGROUND: Ovarian cancer is one of the leading causes of female death worldwide, with a poor prognosis of advanced patients. Sevoflurane, a volatile anesthetic commonly used in clinical operations, has been reported to have anti-cancer activity against some tumors. In the present study, we aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chuanfeng, Wang, Baosheng, Wang, Xiuqin, Sheng, Xiugui, Cui, Yongchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916020/
https://www.ncbi.nlm.nih.gov/pubmed/31889892
http://dx.doi.org/10.1186/s12935-019-1062-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916020/
https://www.ncbi.nlm.nih.gov/pubmed/31889892
http://dx.doi.org/10.1186/s12935-019-1062-0

Ejemplares similares